GlassScriptPhysician profile
Faten Edriskhalaf
NPI 1427400175
$42,235.77
in general payments reported to CMS, 2019-2025
16 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $60.80 · 2021: $661 · 2022: $797 · 2023: $7,280 · 2024: $11K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $14K · Food and Beverage: $7,727 · Consulting Fee: $1,460 · Entertainment: $744 · Gift: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,580.00 |
| Travel and Lodging | $14,417.25 |
| Food and Beverage | $7,727.20 |
| Consulting Fee | $1,460.00 |
| Entertainment | $744.05 |
| Gift | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $34,095.68 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Cvi Contact Lens |
| Lumenis Be INC | $2,013.44 | 2025 | M22 |
| Glaukos Corporation | $1,500.00 | 2024 | Radius |
| Alcon Vision LLC | $1,138.24 | 2019-2025 | Total30, Precision7, Precision 1 |
| Optos, INC. | $904.79 | 2020-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $631.36 | 2022-2025 | Infuse |
| Johnson & Johnson Vision Care, INC. | $546.43 | 2022-2025 | Acuvue |
| Visionary Optics LLC | $400.00 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $205.60 | 2019 | |
| Sight Sciences, INC. | $149.76 | 2021 | |
| Eyevance Pharmaceuticals LLC | $138.49 | 2021 | |
| Kala Pharmaceuticals, INC. | $124.80 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $121.87 | 2025 | Xdemvy |
| Astellas Pharma US INC | $121.83 | 2025 | Izervay |
| Carl Zeiss Meditec USA, INC. | $94.03 | 2024-2025 | Cirrus Hd-Oct |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $49.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faten Edriskhalaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.